v3.26.1
SEGMENT INFORMATION (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Total revenues    
Total revenues $ 14,950 $ 41,015
Cost of revenues (excluding amortization and depreciation) 1,817 13,558
Research and development expense (excluding share-based compensation expense):    
Research and development expense (excluding share-based compensation expense): 346,382 406,288
General and administrative and salaries and benefits expense (excluding stock based compensation, depreciation and amortization expense) 801,904 622,948
Depreciation 4,106
Amortization 6,736 4,786
Stock based compensation 478,611 636,844
Professional fees 495,296 367,816
Interest income, net (34) (1,103)
Equity in net income from equity method investees 1,048
Other income (23,031) (22,833)
Segment net loss (2,096,837) (1,988,337)
Adjustments and reconciling items
Consolidated net loss (2,096,837) (1,988,337)
Clinical Trials [Member]    
Research and development expense (excluding share-based compensation expense):    
Research and development expense (excluding share-based compensation expense): 198,445 61,352
EDC build [Member]    
Research and development expense (excluding share-based compensation expense):    
Research and development expense (excluding share-based compensation expense): 55,800 18,050
HALO Design [Member]    
Research and development expense (excluding share-based compensation expense):    
Research and development expense (excluding share-based compensation expense): 88,767 298,037
SYNC Project [Member]    
Research and development expense (excluding share-based compensation expense):    
Research and development expense (excluding share-based compensation expense): 23,713
Other research and development [Member]    
Research and development expense (excluding share-based compensation expense):    
Research and development expense (excluding share-based compensation expense): [1] 3,370 5,136
UNITED STATES    
Total revenues    
Total revenues 14,950 20,443
International [Member]    
Total revenues    
Total revenues $ 20,572
[1] Other research and development expenses primarily consist of facilities charges, third party consultant costs, costs related to other product candidates, and other unallocated costs.